🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Giovanni Martinelli

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ORCID: 0000-0002-1025-4210

Also affiliated with Istituti di Ricovero e Cura a Carattere Scientifico, University of Bologna

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.7Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.

Research Square(2020)10.21203/rs.3.rs-51964/v1
Top 5%
4.7DataRank
Top 5%166 citations

Marissa Vignali, Mark Klinger, Jennifer N. Dines, Ian M. Kaplan, Emily Svejnoha +22 more

Papers

Driven by 7 papers — median percentile 88. Top paper: “A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.”.

A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.

Research Square(2020)10.21203/rs.3.rs-51964/v1
Top 5%
4.7DataRank
Top 5%166 citations

Marissa Vignali, Mark Klinger, Jennifer N. Dines, Ian M. Kaplan, Emily Svejnoha +22 more

Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T‐cell acute lymphoblastic leukemia and lymphoma

Cancer(2020)10.1002/cncr.33188
N/A
1.2DataRank · unranked
37 citations

Giovanni Martinelli, Emmanuel Raffoux, Patrice Chevallier, Jörg Chromik, Andrew Lithio +6 more

A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2

Frontiers in Immunology(2025)10.3389/fimmu.2025.1488851
Top 20%
1.0DataRank
Top 20%45 citations

Marissa Vignali, Mark Klinger, Jennifer N. Dines, Ian M. Kaplan, Emily Svejnoha +24 more

Long-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapy

Haematologica(2024)10.3324/haematol.2024.285448
N/A
0.241DataRank · unranked
4 citations

Erika Borlenghi, Mark R. Litzow, John C. Byrd, Cristina Papayannidis, Cristina Tecchio +34 more

TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors

Cancer Research(2021)10.1158/0008-5472.can-20-3761
N/A
0DataRank · unranked
52 citations

Bac Viet Le, Margaret Nieborowska-Skorska, Konstantin Golovine, Katherine Sullivan-Reed, Wangisa M.B. Dunuwille +30 more

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

UNC Libraries(2020)10.17615/h6kv-p452
N/A
0DataRank · unranked
0 citations

François Guilhot, Martin Müller, Jiřı́ Mayer, Richard A. Larson, Susanne Saußele +14 more

Data from TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors

(2023)10.1158/0008-5472.c.6513157.v1
N/A
0DataRank · unranked
0 citations

Bac Viet Le, Margaret Nieborowska-Skorska, Konstantin Golovine, Katherine Sullivan-Reed, Wangisa M.B. Dunuwille +30 more